RESPIRATORY INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS, PRIMARY AND SECONDARY AFS BEFORE AND AFTER VACCINATION WITH 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE

被引：0
|
作者：
Koilubaeva, G. [1 ]
Tarasova, G. [2 ]
Belov, B. [2 ]
Bolotbekova, A. [1 ]
Syunbai, K. G. [1 ]
Turatbekova, A. [1 ]
机构：
[1] Rheumatol, 3 Togolok Moldo St, Bishkek, Kyrgyzstan
[2] Rheumatol, Kashirskoye Shosse 34, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Vaccination/immunization;
D O I：
10.1136/annrheumdis-2023-eular.942
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1668
引用
收藏
页码：2070 / 2071
页数：2
相关论文
共 50 条
  • [1] SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1180
  • [2] CLINICAL EFFICACY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Egorova, O.
    Reshetnyak, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1369 - 1370
  • [3] Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus
    Alyasin, Soheila
    Adab, Marzieh
    Hosseinpour, Asieh
    Amin, Reza
    Babaei, Maryam
    IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (03) : 204 - 219
  • [4] INFLUENCE OF VARIOUS FACTORS ON THE IMMUNOGENICITY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 614 - 615
  • [5] USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPY
    Tarasova, Galina
    Belov, Boris
    Bukhanova, Daria
    Cherkasova, Maria
    Solovyev, Sergey
    Aseeva, Elena
    Reshetnyak, Tatiana
    Popkova, Tatiana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 785 - 786
  • [6] IMMUNOGENICITY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: EFFECT OF BIOLOGIC THERAPY ON THE VACCINAL RESPONSE
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Solovyev, S.
    Aseeva, E.
    Reshetnyak, T.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 673 - 673
  • [7] 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
    Tanimoto, Tetsuya
    Kusumi, Eiji
    Hosoda, Kazutaka
    Hamaki, Tamae
    Takahashi, Kenzo
    LANCET INFECTIOUS DISEASES, 2017, 17 (07): : 692 - 693
  • [8] 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
    Suzuki, Motoi
    Dhoubhadel, Bhim Gopal
    Katoh, Shungo
    Ariyoshi, Koya
    Morimoto, Konosuke
    LANCET INFECTIOUS DISEASES, 2017, 17 (08): : 803 - 804
  • [9] Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE)
    Sacre, Karim
    Goulenok, Tiphaine
    Bahuaud, Mathilde
    Francois, Chrystel
    Van der Haegen, Marie Claude
    Alexandra, Jean-Francois
    Aucouturier, Pierre
    Hurtado-Nedelec, Maria
    Moins-Teisserenc, Helene
    Batteux, Frederic
    Papo, Thomas
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (10) : 1540 - +
  • [10] Analysis of Vaccination Rates of 23-Valent Pneumococcal Polysaccharide Vaccine in Hospitalized Patients with Diabetes
    Seagroves, Amy
    Reh, Christina S.
    Bischoff, Nathaniel
    Nally, Laura M.
    Singh, Jasjit
    DIABETES, 2017, 66 : A377 - A378
12345